24 February 2023 (Friday) - Transfusion Evidence Alert


The nice people at Transfusion Evidence Alert sent their update today… Just the thing to round off my week’s holiday

ARTICLE OF THE MONTH

Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients.Abrahamyan, L., et al. (2023). JAMA Surgery. [Record in Progress].PICO Summary available

+++++

TOP ARTICLES

Antifibrinolytics use during surgery for oncological spine diseases: A systematic review.Avila, M.J., et al. (2022). Surgical Neurology International.

The ICaRAS randomised controlled trial: Intravenous iron to treat anaemia in people with advanced cancer - feasibility of recruitment, intervention and delivery.Dickson, E.A., et al. (2023). Palliative Medicine. [Record in Progress].

Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.Foong, W.C., et al. (2023). The Cochrane Database of Systematic Reviews.

Impact of time and distance on outcomes following tourniquet use in civilian and military settings: A scoping review.Joarder, M., et al. (2023). Injury. [Record in Progress].

What blood conservation practices are effective at reducing blood sampling volumes and other clinical sequelae in intensive care? A systematic review.Keogh S., et al. (2023). Australian Critical Care. [Record in Progress].

Should adding pain, oxygen saturation and physical assessment to vital signs become the new standard of care for detecting blood transfusion reactions?Roney, J.K., et al. (2022). Vox sanguinis.

The Impact of Restrictive Transfusion Practices on Hemodynamically Stable Critically Ill Children Without Heart Disease: A Secondary Analysis of the Age of Blood in Children in the PICU Trial.Steffen, K.M., et al. (2023). Pediatric Critical Care Medicine.

Benefits of pre-operative oral Sucrosomial(®) iron supplementation in cardiac surgery: influence of patient's baseline hemoglobin and gender.Weltert, L.P., et al. (2022). Blood Transfusion. [Record in Progress].

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.Denkinger, C.M., et al. (2022). Nature Cancer.

No comments:

Post a Comment